(E)-4-Hydroxycrotonic Acid | CAS:24587-49-3

We serve (E)-4-Hydroxycrotonic Acid CAS:24587-49-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(E)-4-Hydroxycrotonic Acid

Chemical Name:(E)-4-Hydroxycrotonic Acid
CAS.NO:24587-49-3
Synonyms:(E)-4-Hydroxycrotonic Acid
4-hydroxy-but-2-enoic acid
 
Physical and Chemical Properties:
Boiling Point 338.7ºC at 760 mmHg
Molecular Formula C4H6O3
Molecular Weight 102.08900
Flash Point 172.9ºC
 
Specification:
Appearance:Light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Neratinib(CAS:698387-09-6).



Contact us for information like (E)-4-Hydroxycrotonic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-hydroxy-but-2-enoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(E)-4-Hydroxycrotonic Acid Use and application,4-hydroxy-but-2-enoic acid technical grade,usp/ep/jp grade.


Related News: Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies.(S)-(+)-3-Hydroxytetrahydrofuran manufacturer The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15.2-Methoxy-3-(trifluoromethyl)pyridine supplier The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.6-Chloro-5-methylpyridin-3-amine vendor At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.